Self-peptide/MHC and TCR antagonism: Physiological role and therapeutic potential

Cellular Immunology

Volumn 233, Issue 2, 2005, Pages 75-84

  Vukmanović, Stanislav ^a   Santori, Fabio R ^b  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antagonism; MHC; T cell receptor

Indexed keywords

CHORIONIC GONADOTROPIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; LIGAND; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; CELL MATURATION; CELL SPECIFICITY; CONFERENCE PAPER; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; EXPERIMENTAL THERAPY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROBIAL ACTIVITY; MICROORGANISM; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; AUTOANTIGENS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNOTHERAPY; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL;

EID: 23044497611     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2005.04.011     Document Type: Conference Paper

References (122)

1. J. Sloan-Lankaster, and P.M. Allen Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology Annu. Rev. Immunol. 14 1996 1 27
2. M.T. De Magistris, J. Alexander, M. Coggeshall, A. Altman, F.C.A. Gaeta, H.N. Grey, and A. Sette Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor Cell 68 1992 625 634
3. S.J. Jameson, F.R. Carbone, and M.J. Bevan Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells J. Exp. Med. 177 1993 1541 1550
4. S.C. Jameson, and M.J. Bevan T cell receptor antagonists and partial agonists Immunity 2 1995 1 11
5. J. Alexander, K. Snoke, J. Ruppert, J. Sidney, M. Wall, S. Southwood, C. Oseroff, T. Arrhenius, F.C.A. Gaeta, S.M. Colon, H.N. Grey, and A. Sette Functional consequences of engagement of the T cell receptor by low affinity ligands J. Immunol. 150 1993 1
6. S.M. Alam, P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R.J. Gascoigne T-cell receptor affinity and thymocyte positive selection Nature 381 1996 616 620
7. P. Klenerman, S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Koppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R.E. Phillips, and A.J. McMichael Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants Nature 369 1994 403 407
8. A. Bertoletti, A. Sette, F. Chisari, A. Penna, M. Levrero, M. De Carli, F. Fiaccadori, and C. Ferrari Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells Nature 369 1994 407 410
9. S.T. Yoon, U. Dianzani, K. Bottomly, and C.A.J. Janeway Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity Immunity 1 1994 563 569
10. B.M. Baker, S.J. Gagnon, W.E. Biddison, and D.C. Wiley Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: implications for TCR signaling Immunity 13 2000 475 484
11. k complexes: correlation of the dissociation rate with T-cell responsiveness Proc. Natl. Acad. Sci. USA 91 1994 12862 12866
12. G.J. Kersh, E.N. Kersh, D.H. Fremont, and P.M. Allen High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling Immunity 9 1998 817 826
13. F.R. Santori, K. Holmberg, D. Ostrov, N.R.J. Gascoigne, and S. Vukmanovic Distinct footprints of T cell receptor engagement with highly homologous ligands J. Immunol. 172 2004 7466 7475
14. C. Rosette, G. Werlen, M.A. Daniels, P.O. Holman, S.M. Alam, P.J. Travers, N.R.J. Gascoigne, E. Palmer, and S.C. Jameson The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model Immunity 15 2001 59 70
15. C.A.J. Janeway Ligands for the T cell receptor: hard times for avidity models Immunol. Today 16 1995 223 225
16. K.C. Garcia, M. Degano, L.R. Pease, M. Huang, P.A. Peterson, L. Teyton, and I.A. Wilson Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen Science 279 1998 1166 1172
17. J.B. Reiser, C. Gregoire, C. Darnault, T. Mosser, A. Guimezanes, A.M. Schmitt-Verhulst, J.C. Fontecilla-Camps, G. Maza, B. Malissen, and D. Housset A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex Immunity 16 2002 345 354
18. L. Kjer-Nielsen, C.S. Clements, A.W. Purcell, A.G. Brooks, J.C. Whisstock, S.R. Burrows, J. McCluskey, and J. Rossjohn A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity Immunity 18 2003 53 64
19. Y.-H. Ding, B.M. Baker, D.N. Garboczi, W.E. Biddison, and D.C. Wiley Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical Immunity 11 1999 45 56
20. M.G. Rudolph, and I.A. Wilson The specificity of TCR/pMHC interaction Curr. Opin. Immunol. 14 2002 52 65
21. A.J. Bankovich, and K.C. Garcia Not just any T cell receptor will do Immunity 18 2003 7 11
22. D. Housset, and B. Malissen What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity? Trends Immunol. 24 2003 429 437
23. L.C. James, P. Roversi, and D.S. Tawfik Antibody multispecificity mediated by conformational diversity Science 299 2003 1362 1367
24. N.R.J. Gascoigne, and T. Zal Molecular interactions at the T cell-antigen-presenting cell interface Curr. Opin. Immunol. 16 2004 114 119
25. H. Liu, and D.A. Vignali Differential CD3 zeta phosphorylation is not required for the induction of T cell antagonism by altered peptide ligands J. Immunol. 163 1999 599 602
26. L.A. Pitcher, P.S. Ohashi, and N.S.C. van Oers T cell antagonism is functionally uncoupled from the 21- and 23-kDa tyrosine-phosphorylated TCR ζ subunits J. Immunol. 171 2003 845 852
27. J. Sloan-Lancaster, A.S. Shaw, J.B. Rothbard, and P.M. Allen Partial T cell signaling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell clonal anergy Cell 79 1994 913 922
28. J. Madrenas, R.L. Wange, J.L. Wang, N. Isakov, L.E. Samelson, and R.N. Germain ζ phosphorylation without ZAP-70 activation induced by TCR antagonists of partial agonists Science 267 1995 515 518
29. B.D. Evavold, J. Sloan-Lancaster, and P.M. Allen Antagonism of superantigen-stimulated helper T-cell clones by altered peptide ligand Proc. Natl. Acad. Sci. USA 91 1994 2300 2304
30. B.N. Dittel, I. Stefanova, R.N. Germain, and C.A.J. Janeway Cross-antagonism of a T cell clone expressing two distinct T cell receptors Immunity 11 1999 289 298
31. N.E. Kilgore, J.D. Carter, U. Lorenz, and B.D. Evavold Cutting edge: dependence of TCR antagonism on Src homology 2 domain-containing protein tyrosine phosphatase activity J. Immunol. 170 2003 4891 4895
32. I. Stefanova, B. Hemmer, M. Vergelli, R. Martin, W.E. Biddison, and R.N. Germain TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways Nat. Immunol. 4 2003 248 254
33. S.H. Slotz, L. Bolliger, F.R. Carbone, and E. Palmer T cell receptor (TCR) antagonism without a negative signal: evidence from T cell hybridomas expressing two independent TCRs J. Exp. Med. 189 1999 253 264
34. M.A. Daniels, S.L. Schober, K.A. Hogquist, and S.C. Jameson Cutting edge: a test of the dominant negative signal model for TCR antagonism J. Immunol. 162 1999 3761 3764
35. J.M. Robertson, and B.D. Evavold Cutting edge: dueling TCRs: peptide antagonism of CD4+ T cells with dual antigen specificities J. Immunol. 163 1999 1750 1754
36. W. Yang, and H.M. Grey Study of the mechanism of TCR antagonism using dual-TCR-expressing T cells J. Immunol. 170 2003 4532 4538
37. L.L. Lanier NK cell receptors Annu. Rev. Immunol. 16 1998 359 393
38. K.G. Johnson, F.G. LeRoy, L.K. Borysiewicz, and R.J. Matthews TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1 J. Immunol. 162 1999 3802 3813
39. M.F. Bachmann, D.E. Speiser, A. Zakarian, and P.S. Ohashi Inhibition of TCR triggering by a spectrum of altered peptide ligands suggests the mechanism for TCR antagonism Eur. J. Immunol. 28 1998 3110 3119
40. S.C. Jameson, K.A. Hogquist, and M.J. Bevan Positive selection of thymocytes Ann. Rev. Immunol. 13 1995 93 126
41. S. Vukmanovic The molecular jury: deciding whether immature thymocytes should live or die J. Exp. Med. 184 1996 305 309
42. C.D. Surh, and J. Sprent T-cell apoptosis detected in situ during positive and negative selection in the thymus Nature 372 1994 100 103
43. + T cells Immunity 3 1995 79 86
44. K.A. Hogquist, S.C. Jameson, W.R. Heath, M.J. Howard, J.L. Bevan, and F.R. Carbone T cell receptor antagonist peptides induce positive selection Cell 76 1994 17 27
45. S.C. Jameson, K.A. Hogquist, and M.J. Bevan Specificity and flexibility in thymic selection Nature 369 1994 750 752
46. E. Sebzda, T.M. Kundig, C.T. Thomson, K. Aoki, S.-Y. Mak, J.P. Mayer, T. Zamborelli, S.G. Nathenson, and P.S. Ohashi Mature T cell reactivity altered by peptide agonist that induces positive selection J. Exp. Med. 183 1996 1093 1104
47. Y. Ghendler, M.K. Teng, J.H. Liu, T. Witte, J. Liu, K.S. Kim, P. Kern, H.C. Chang, J.H. Wang, and E.L. Reinherz Differential thymic selection outcomes stimulated by focal structural alteration in peptide/major histocompatibility complex ligands Proc. Natl. Acad. Sci. USA 95 1998 10061 10066
48. A. Volkmann, T. Barthlott, S. Weiss, R. Frank, and B. Stockinger Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage J. Exp. Med. 188 1998 1083 1089
49. F.R. Santori, S.M. Brown, Y. Lu, T.A. Neubert, and S. Vukmanovic Cutting edge: positive selection induced by a self peptide with TCR antagonist activity J. Immunol. 167 2001 6092 6095
50. F.R. Santori, W.C. Kieper, S.M. Brown, Y. Lu, T.A. Neubert, K.L. Johnson, S. Naylor, S. Vukmanovic, K.A. Hogquist, and S.C. Jameson Rare, structurally homologous self-peptides promote thymocyte positive selection Immunity 17 2002 131 142
51. M.D. Mannie A unified model for T cell recognition and thymic selection of the T cell repertoire J. Theor. Biol. 151 1991 169 192
52. C.A.J. Janeway High fives or hand clasps? Curr. Biol. 2 1992 591 593
53. O. Williams, Y. Tanaka, R. Tarazona, and D. Kioussis The agonist-antagonist balance in positive selection Immunol. Today 18 1997 121 126
54. C.B. Williams, K. Vidal, D. Donermeyer, D.A. Peterson, J.M. White, and P.M. Allen In vivo expression of a TCR antagonist: T cells escape central tolerance but are antagonized in the periphery J. Immunol. 161 1998 128 137
55. D. Basu, C.B. Williams, and P.M. Allen In vivo antagonism of a T cell response by an endogenously expressed ligand Proc. Natl. Acad. Sci. USA 95 1998 14332 14336
56. D.M. Page, J. Alexander, K. Snoke, E. Appella, A. Sette, S.M. Hedrick, and H.M. Grey Negative selection of CD4+CD8+ thymocytes by T-cell receptor peptide antagonists Proc. Natl. Acad. Sci. USA 91 1944 4057 4061
57. O. Williams, Y. Tanaka, M. Bix, M. Murdjeva, D.R. Littman, and D. Kioussis Inhibition of thymocyte negative selection by T cell receptor antagonist peptides Eur. J. Immunol. 26 1996 532 538
58. L.M. Spain, J.L. Jorgensen, M.M. Davis, and L.J. Berg A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes J. Immunol. 152 1994 1709 1717
59. C.N. Levelt, E. Mizoguchi, X. Huang, R. Zacks, A.K. Bhan, and S. Tonegawa Inhibition of intrathymic T cell development by expression of a transgenic antagonist peptide Proc. Natl. Acad. Sci. USA 95 1998 14349 14354
60. + T cells is induced in vivo by agonist and inhibited by antagonist peptides J. Exp. Med. 194 2001 407 416
61. T. Sasada, Y. Ghendler, J.M. Neveu, W.S. Lane, and E.L. Reinherz A naturally processed mitochondrial self-peptide in complex with thymic MHC molecules functions as a selecting ligand for a viral-specific T cell receptor J. Exp. Med 194 2001 883 892
62. S.D. Saibil, T. Ohteki, F.M. White, M. Luscher, A. Zakarian, A. Elford, J. Shabanowitz, H. Nishina, P. Hugo, J. Penninger, B. Barber, D.F. Hunt, and P.S. Ohashi Weak agonist self-peptides promote selection and tuning of virus-specific T cells Eur. J. Immunol. 33 2003 685 696
63. C. Tanchot, F.A. Lemonnier, B. Perarnau, A. Freitas, and B. Rocha Differential requirements for survival and proliferation of CD8 naive or memory T cells Science 276 1997 2057 2062
64. + thymic emigrants J. Immunol. 160 1998 3705 3712
65. S. Takeda, H.-R. Rodewald, H. Arakawa, H. Bluethmann, and T. Shimizu MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span Immunity 5 1996 217 228
66. + T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells J. Exp. Med. 186 1997 1223 1232
67. R. Rooke, C. Waltzinger, C. Benoist, and D. Mathis Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses Immunity 7 1997 123 134
68. J. Kirberg, A. Berns, and H. von Boehmer Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules J. Exp. Med. 186 1997 1269 1275
69. R. Zamoyska, A. Basson, A. Filby, G. Legname, M. Lovatt, and B. Seddon The influence of the src-family kinases, Lck and Fyn, on T cell differentiation, survival and activation Immunol. Rev. 191 2003 107 118
70. C. Viret, F.S. Wong, and C.A.J. Janeway Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition Immunity 10 1999 559 568
71. B. Ernst, D.-S. Lee, J.M. Chang, J. Sprent, and C.D. Surh The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery Immunity 11 1999 173 181
72. + pool in MHC class I deficient mice J. Immunol. 165 2000 1896 1901
73. + T cells in lymphopenic hosts Immunity 11 1999 183 190
74. H. Pircher, D. Moskophidis, U. Rohrer, K. Burki, H. Hengartner, and R.M. Zinkernagel Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo Nature 346 1990 629 633
75. L. Pewe, G.F. Wu, E.M. Barnett, R.F. Castro, and S. Perlman Cytotoxic T cell-resistant variants are selected in a virus-induced demyelinating disease Immunity 5 1996 253 262
76. C.B. Moore, M. John, I.R. James, F.T. Christiansen, C.S. Witt, and S.A. Mallal Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level Science 296 2002 1439 1443
77. L. Pewe, S. Xue, and S. Perlman Infection with cytotoxic T-lymphocyte escape mutants results in increased mortality and growth retardation in mice infected with a neurotropic coronavirus J. Virol. 72 1998 5912 5918
78. P. Klenerman, and R.M. Zinkernagel Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes Nature 394 1998 482 485
79. A.L. Erickson, Y. Kimura, S. Igarashi, J. Eichelberger, M. Houghton, J. Sidney, D. McKinney, A. Sette, A.L. Hughes, and C.M. Walker The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes Immunity 15 2001 883 895
80. D.H. O'Connor, T.M. Allen, T.U. Vogel, P. Jing, I.P. DeSouza, E. Dodds, E.J. Dunphy, C. Melsaether, B. Mothe, H. Yamamoto, H. Horton, N. Wilson, A.L. Hughes, and D.I. Watkins Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection Nat. Med. 8 2002 493 499
81. D.H. Barouch, J. Kunstman, M.J. Kuroda, J.E. Schmitz, S. Santra, F.W. Peyerl, G.R. Krivulka, K. Beaudry, M.A. Lifton, D.A. Gorgone, D.C. Montefiori, M.G. Lewis, S.M. Wolinsky, and N.L. Letvin Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes Nature 415 2002 335 339
82. O.O. Yang CTL ontogeny and viral escape: implications for HIV-1 vaccine design Trends Immunol. 25 2004 138 142
83. P.O. deCampos-Lima, R. Gavioli, Q.J. Zhang, L.E. Wallace, R. Dolcetti, M. Rowe, A.B. Rickinson, and M.G. Masucci HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population Science 260 1993 98 100
84. A.B. Rickinson, and D.J. Moss Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection Annu. Rev. Immunol. 15 1997 405 431
85. D.J. Loftus, P. Squarcina, M.B. Nielsen, C. Geisler, C. Castelli, N. Odum, E. Appella, G. Parmiani, and L. Rivoltini Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35) Cancer Res. 58 1998 2433 2439
86. T. Ohteki, A. Hessel, M.F. Bachmann, A. Zakarian, E. Sebzda, M.S. Tsao, K. McKall-Faienza, B. Odermatt, and P.S. Ohashi Identification of a cross-reactive self ligand in virus-mediated autoimmunity Eur. J. Immunol. 29 1999 2886 2896
87. D. Hudrisier, J. Riond, O. Burlet-Schiltz, M.G. vonHerrath, H. Lewicki, B. Monsarrat, M.B. Oldstone, and J.E. Gairin Structural and functional identification of major histocompatibility complex class I-restricted self-peptides as naturally occurring molecular mimics of viral antigens. Possible role in CD8+ T cell-mediated, virus-induced autoimmune disease J. Biol. Chem. 2001
88. + T cell response to antigen by the levels of self MHC class I J. Immunol. 166 2001 5416 5421
89. I. Stefanova, J.R. Dorfman, and R.N. Germain Self recognition promotes the foreign antigen sensitivity of naive T lymphocytes Nature 420 2002 429 434
90. K. Smith, B. Seddon, M.A. Purbhoo, R. Zamoyska, A.G. Fisher, and M. Merkenschlager Sensory adaptation in naive peripheral CD4 T cells J. Exp. Med 194 2001 1253 1261
91. S. Vukmanovic, T.A. Neubert, and F.R. Santori Could TCR antagonism explain associations between MHC genes and disease? Trends Mol. Med. 9 2003 139 146
92. H. Hendel, S. Caillat-Zucman, H. Lebuanec, M. Carrington, S. O'Brien, J.M. Andrieu, F. Schachter, D. Zagury, J. Rappaport, C. Winkler, G.W. Nelson, and J.F. Zagury New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS J. Immunol. 162 1999 6942 6946
93. H.A. Priem, A. Kijlstra, L. Noens, G.S. Baarsma, J.J. DeLaey, and J.A. Oosterhuis HLA typing in birdshot chorioretinopathy Am. J. Ophthalmol. 105 1988 182 185
94. Y. Szpak, J.C. Vieville, T. Tabary, M.C. Naud, M. Chopin, C. Edelson, J.H. Cohen, J. Dausset, Y. de Kozak, and M. Pla Spontaneous retinopathy in HLA-A29 transgenic mice Proc. Natl. Acad. Sci. USA 98 2001 2572 2576
95. A. Sette, J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H. Grey Antigen analogs/MHC complexes as specific T cell receptor antagonists Annu. Rev. Immunol. 12 1994 413 431
96. A. Franco, S. Southwood, T. Arrhenius, V.K. Kuchroo, H.M. Grey, A. Sette, and G.Y. Ishioka T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis Eur. J. Immunol. 24 1994 940 946
97. V.K. Kuchroo, J.M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R.A. Sobel, and M.B. Lees A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire J. Immunol. 153 1994 3326 3336
98. A. Windhagen, C. Scholz, P. Hollsberg, H. Fukaura, A. Sette, and D.A. Hafler Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand Immunity 2 1995 373 380
99. E. Zisman, Y. Katz-Levy, M. Dayan, S.L. Kirshner, M. Paas-Rozner, A. Karni, O. Abramski, C. Brautbar, M. Fridkin, M. Sela, and E. Mozes Peptide analogs to pathogenic epitopes of the human acetylcholine receptor α subunit as potential modulators of myasthenia gravis Proc. Natl. Acad. Sci. USA 93 1996 4492 4497
100. S.M. Anderton, S. Kissler, A.G. Lamont, and D.C. Wraith Therapeutic potential of TCR antagonists is determined by their ability to modulate a diverse repertoire of autoreactive T cells Eur. J. Immunol. 1999 29
101. M.L. Ford, and B.D. Evavold Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55 J. Immunol. 171 2003 1247 1254
102. S. Ikagawa, S. Matsushita, Y.Z. Chen, T. Ishikawa, and Y. Nishimura Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j)1-derived peptide induced alterations in human T cell responses and T cell receptor antagonism J. Allergy Clin. Immunol. 97 1996 53 64
103. R. De Palma, S. Wu, F. Sullusto, G. DiFelice, P. Martucci, D. Geraci, P. Colombo, C. Troise, G. Sacerdoti, A. Nocera, and J. Gorski Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen J. Immunol. 162 1999 1982 1987
104. A.I. Colovai, Z. Liu, P.E. Harris, R. Cortesini, and N. Suciu-Foca Allopeptide-specific T cell reactivity altered by peptide analogs J. Immunol. 158 1997 48 54
105. C. Daniel, A. Grakoui, and P.M. Allen Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands J. Immunol. 160 1998 3244 3250
106. S.R. Borrows, R. Khana, and D.J. Moss Direct alloreactivity by human cytotoxic T lymphocytes can be inhibited by altered peptide ligand antagonism Blood 93 1999 1020 1024
107. L. Frasca, A. Tamir, S. Jurcevic, B. Marinari, A. Monizio, R. Sorrentino, M. Carbonari, E. Piccolella, R.I. Lechler, and G. Lombardi Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity Transplantation 70 2000 631 640
108. M. Garcia-Peydro, A. Paradela, J.P. Albar, and J.A. Castro Antagonism of direct alloreactivity of an HLA-B27-specific CTL clone by altered peptide ligands of its natural epitope J. Immunol. 165 2000 5680 5685
109. I. Messaoudi, J.A. Guevara Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich Direct link between mhc polymorphism, T cell avidity, and diversity in immune defence Science 298 2002 1797 1800
110. M. Plebanski, E.A. Lee, C.M. Hannan, K.L. Flanagan, S.C. Gilbert, M.B. Gravenor, and A.V. Hill Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming Nat. Med. 5 1999 565 571
111. b recognition J. Immunol. 152 1994 1790 1801
112. H.J. Hernandez, and M.J. Stadecker Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease J. Immunol. 163 1999 3877 3882
113. M. Toda, M. Totsuka, S. Furukawa, K. Yokota, T. Yoshioka, A. Ametani, and S. Kaminogawa Down-regulation of antigen-specific antibody production by TCR antagonist peptides in vivo Eur. J. Immunol. 30 2000 403 414
114. L. Kappos, G. Comi, H. Panitch, J. Oger, J. Antel, P. Conlon, L. Steinman, T.a.p.l.i.r.M.S. group. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat. Med. 6 (2000) 1176-1182.
115. B. Bielekova, B. Goodwin, N. Richert, I. Cortese, T. Kondo, G. Afshar, B. Gran, J. Eaton, J. Antel, J.A. Frank, H.F. McFarland, and R. Martin Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand Nat. Med. 6 2000 1167 1175
116. P.D. Crowe, Y. Qin, P.J. Conlon, and J.P. Antel NBI-5788, an altered MBP83-99 peptide, induces a T-helper 2-like immune response in multiple sclerosis patients Ann. Neurol. 48 2000 758 765
117. J.J. Lafaille The role of helper T cell subsets in autoimmune diseases Cytokine Growth Factor Rev. 9 1998 139 151
118. H. Lassmann, and R.M. Ransohoff The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal Trends Immunol. 25 2004 132 137
119. J.J. Lafaille, F.V. Keere, A.L. Hsu, J.L. Baron, W. Haas, C.S. Raine, and S. Tonegawa Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect from the disease J. Exp. Med. 186 1997 307 312
120. A. Wensky, M.C. Garibaldi Marcondes, and J.J. Lafaille The role of IFN-g in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity J. Immunol. 167 2001 3074 3081
121. C.F. Lucchinetti, R.N. Mandler, D. McGovern, W. Bruck, G. Gleich, R.M. Ransohoff, C. Trebst, B. Weinshenker, D. Wingerchuk, J.E. Parisi, and H. Lassmann A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica Brain 125 2002 1450 1461
122. F. Ramsdell, and S.F. Ziegler Transcription factors in autoimmunity Curr. Opin. Immunol. 15 2003 718 724